We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Drugs as Effective as Surgery for GERD

By HospiMedica staff writers
Posted on 09 Jan 2006
A new study of available data regarding gastroesophageal reflux disease (GERD), concludes that drugs can be just as effective as surgery in managing disease symptoms. More...


GERD occurs when stomach acid backs up into the esophagus, triggering heartburn and sometimes causing esophageal damage. In most patients this is due to a transient relaxation of the "gate” or sphincter that keeps the lower end of the esophagus closed when a person is not swallowing food or liquids.

The findings showed that for chronic GERD, over-the-counter H2 receptor antagonist medications are not as effective as proton pump inhibitors (PPIs), although PPIs have more side effects. PPIs appear to have similar clinical effectiveness when compared to each another. Compared to surgery, PPIs appear to be similarly effective in relieving symptoms and improving quality of life.

Dr. Gerald Berke, a professor of surgery at the University of California, Los Angeles (UCLA, USA), commented on the report. "In general, patients with GERD do respond to both surgical and medical treatment; however, the mainstay of therapy, which is not addressed, is alteration of diet and eating and sleeping habits. In addition, a small, but significant group of patients do not seem to respond to either medical, surgical management, or lifestyle modification, and the reason for their failure rate is currently unknown.”

The study is the first in a series from the Agency for Healthcare Research and Quality (AHRQ, Rockville, MD, USA) that compares treatments for common illnesses. The goal of these studies is to give the public and healthcare workers the latest evidence-based treatment recommendations.

"We are trying to make the information as transparent and as accessible as possible about what we know from the latest science,” said Dr. Carolyn M. Clancy, director of AHRQ, which conducted the study. Future reports will focus on breast cancer screening, drugs for depression, and managing diabetes.






Related Links:
Agency for Healthcare Research and Quality (AHRQ)

Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Multi-Chamber Washer-Disinfector
WD 390
New
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.